Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,262 public trials 443 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

Implementing Long-Acting Novel Antiretrovirals

NCT05294159

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Brighton and Sussex University Hospitals NHS Trust Brighton, United Kingdom
  • Royal Liverpool University Hospital Liverpool, United Kingdom
  • Blizard Institute London, United Kingdom
  • Royal Free Hospital NHS London, United Kingdom
View Trial Details
Completed

A Study of JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection

NCT04667104

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Tokyo Medical and Dental University Hospital Bunkyō City, Japan
  • Osaka University Hospital Suita-shi, Japan
  • New Zealand Clinical Research Auckland, New Zealand
  • Middlemore Clinical Trials Papatoetoe, New Zealand
View Trial Details
Completed

Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors

NCT03382834

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Ucsf Hiv/Aids Crs San Francisco, California, United States
  • Harbor-UCLA CRS Torrance, California, United States
View all 15 locations
View Trial Details
Completed

A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years

NCT00799864

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Syracuse, New York, United States
  • Memphis, Tennessee, United States
  • Chennai, India
  • Mangalore, India
View all 17 locations
View Trial Details
Completed

A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects

NCT02120352

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Beverly Hills, California, United States
  • GSK Investigational Site Long Beach, California, United States
View all 50 locations
View Trial Details

Related conditions